ALB and type 2 diabetes mellitus: American Diabetes Association (ADA) recommends that the use of an SGLT2i for patients with T2D and DKD having an eGFR ≥ 30 mL/min/1.73 m2 and urinary albumin-to-creatinine ratio (UACR) > 30 mg/g, particularly in those with UACR > 300 mg/g [2].